These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18161757)

  • 21. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A
    Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.
    Smyk-Pearson S; Golden-Mason L; Klarquist J; Burton JR; Tester IA; Wang CC; Culbertson N; Vandenbark AA; Rosen HR
    J Infect Dis; 2008 Jan; 197(1):46-57. PubMed ID: 18171284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral applications of Toll-like receptor agonists.
    Horscroft NJ; Pryde DC; Bright H
    J Antimicrob Chemother; 2012 Apr; 67(4):789-801. PubMed ID: 22258929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concentration of IL-10, IL-13 and IFN-gamma cytokines in supernatants of microcultured CD4+ and NK cells in patients with non-allergic bronchial asthma].
    Stasiak-Barmuta A; Stankiewicz W; Chciałowski A; Moniuszko T; Alifier M
    Pol Merkur Lekarski; 2008 Jan; 24(139):8-13. PubMed ID: 18634243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8+ regulatory T cells in persistent human viral infections.
    Billerbeck E; Thimme R
    Hum Immunol; 2008 Nov; 69(11):771-5. PubMed ID: 18789990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.
    Labro MT
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):319-40. PubMed ID: 22397566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host.
    Liu XS; Leerberg J; MacDonald K; Leggatt GR; Frazer IH
    J Immunol; 2009 Jul; 183(1):51-8. PubMed ID: 19535638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-viral immunodeficiencies in man.
    Hobbs JR
    Clin Ter; 1992 Feb; 140(2):115-21. PubMed ID: 1568355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells.
    Wang J; Su B; Ding Z; Du X; Wang B
    Biochem Biophys Res Commun; 2008 Aug; 372(3):491-6. PubMed ID: 18502198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
    Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
    J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distinct role of T cell costimulation in antiviral immunity.
    Welten SP; Melief CJ; Arens R
    Curr Opin Virol; 2013 Aug; 3(4):475-82. PubMed ID: 23850168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs).
    Kotwal GJ
    Vaccine; 2008 Jun; 26(24):3055-8. PubMed ID: 18241960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cartilage proteoglycan-specific T cells as vectors of immunomodulatory biologicals in chronic proteoglycan-induced arthritis.
    Guichelaar T; ten Brink CB; van Kooten PJ; Berlo SE; Lafeber FP; Broeren CP; van Eden W; Broere F
    Mol Immunol; 2008 Aug; 45(13):3526-35. PubMed ID: 18579208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway.
    Ben Ahmed M; Belhadj Hmida N; Moes N; Buyse S; Abdeladhim M; Louzir H; Cerf-Bensussan N
    J Immunol; 2009 Jun; 182(11):6763-70. PubMed ID: 19454671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of infections--a complex interplay between microbes and the immune defence].
    Haug CJ; Müller F
    Tidsskr Nor Laegeforen; 1995 Oct; 115(26):3254-8. PubMed ID: 7482453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasculitis and chronic persistent viral infections.
    Calabrese LH
    Ann Med Interne (Paris); 1998 Nov; 149(7):395-7. PubMed ID: 9921391
    [No Abstract]   [Full Text] [Related]  

  • 38. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
    Ejrnaes M; von Herrath MG; Christen U
    Clin Dev Immunol; 2006; 13(2-4):337-47. PubMed ID: 17162375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of IL-10 in regulating immunity to persistent viral infections.
    Wilson EB; Brooks DG
    Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A chronic viral infection model with immune impairment.
    Wang Z; Liu X
    J Theor Biol; 2007 Dec; 249(3):532-42. PubMed ID: 17900625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.